Drug Pipeline

HS-20093 for Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
2
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-02 NCT07621601 A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal… Phase 3 Not Yet Recruiting
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07621601 A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal… Esophageal Squamous Cell Carcinoma (ESCC) Not Yet Recruiting
Phase 2
NCT07230106 A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer Prostate Cancer Recruiting
Phase 1
NCT07462923 HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma Advanced Gastric and Gastroesophageal Junction Adenocarcinoma Recruiting
Sponsors Running HS-20093 for Injection Trials
Hansoh BioMedical R&D Company (2) Jiangsu HengRui Medicine Co., Ltd. (1)
Disease Areas
Prostate Cancer (1)
Get alerts when HS-20093 for Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free